COMMITMENTS AND CONTINGENCIES (Details) - USD ($) |
1 Months Ended | ||
---|---|---|---|
Feb. 28, 2018 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
Contingency | |||
Accrued research and development | $ 2,263,934 | $ 1,405,536 | |
ACX362E | |||
Contingency | |||
Future commitment | $ 700,000 | ||
Royalty payments | $ 50,000 | ||
Accrued research and development | $ 150,000 | ||
Royalty payments on net sales (as a percent) | 4.00% |
X | ||||||||||
- Definition Amount carrying value as of the balance sheet date of accrued research and development Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). No definition available.
|
X | ||||||||||
- Definition Represents for percentage of royalty payments on net sales. No definition available.
|
X | ||||||||||
- Definition Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|